Glooko stock

Private-market facts for current and former Glooko employees researching their stock.

Latest Round
Series E
Valuation
Not publicly disclosed
Founded
2010
Headquarters
Palo Alto, CA
Founders
Yogen Dalal, Sundeep Madra, Anand Iyer
Status
private
Employees
235 -23% YoY
Total Raised
$95M

Talk to a Glooko stock specialist

Get personalized guidance on your Glooko shares — including current market activity, pricing context, and liquidity options.

Speak with an expert

Overview

Remote patient monitoring platform for diabetes management that integrates data from glucose monitors, insulin pumps, and other devices.

Glooko outlook

Equity outlook90% data confidence
1x
Base scenario
2x
Upside scenario

For employees evaluating Glooko equity, a 1x base multiple suggests the stock may be close to fairly valued at current prices. The upside scenario at 2x is relatively close to the base case, suggesting more predictable but narrower range of outcomes.

These estimates reflect modeled return scenarios, not guaranteed outcomes. Actual results depend on company performance, market conditions, share class, and timing.

Illustrative model · v1.0.0 · Not investment advice

Selling Glooko shares

Why shareholders consider selling

Shareholders in Glooko may explore liquidity for a number of reasons — diversifying a concentrated position, funding a personal financial goal, or simply reducing exposure to a single private holding. As a private company, Glooko does not trade on a public exchange, meaning employees and early shareholders cannot simply sell through a brokerage. Extended private timelines can leave shareholders waiting years for an exit event, which is why some choose to explore secondary-market options.

Can you sell Glooko stock?

Whether a shareholder can sell typically depends on what they hold and how it was acquired. Vested and exercised shares are generally more straightforward than unexercised options or unvested RSUs. Most private companies, including those in the Healthcare & Biotech sector, impose transfer restrictions such as rights of first refusal or board approval requirements. The specific terms governing Glooko shares would be outlined in the holder's equity agreement or the company's governing documents.

What affects the value of Glooko shares?

The price a buyer is willing to pay for private shares is shaped by several factors: overall demand for the stock, the company's financial performance, broader Healthcare & Biotech market conditions, and any recent private-market transaction activity. Data points such as the company's Series E round can help frame expectations, though they do not guarantee a transaction price.

What should holders check before selling

Tools for Glooko shareholders

Exploring equity in Glooko often raises questions about taxes, exercise timing, valuation, and exit outcomes. These tools can help you model different decisions using your own assumptions.

Latest funding round

Glooko most recently raised a Series E round . Total funding raised to date is approximately $95M.

Glooko funding history

Seed Round 2011
$1M
Series A 2012
$4M
Series A 2014
$7M
Series B 2015
$17M
Series C 2016
$8M
Series C 2017
$35M
Debt Financing 2021
$100M
Series D 2021
$30M
Series F 2024
$100M
Date Round Amount Lead investors
Oct 2024 Series F $100M Georgian
Mar 2021 Series D $30M Health Catalyst Capital
Jan 2021 Debt Financing $100M Armentum Partners
Jun 2017 Series C $35M Georgian
Sep 2016 Series C $8M Canaan Partners
Mar 2015 Series B $17M Medtronic, Canaan Partners
Jan 2014 Series A $7M
Jan 2012 Series A $4M Social Capital
Nov 2011 Seed Round $1M

Glooko IPO & exit outlook

Glooko has not announced a confirmed IPO date or acquisition. Founded 2010, Glooko has been private for 16 years.

For employees holding equity, the timeline to liquidity is uncertain. Options to consider include:

Read our liquidity guide for a full comparison of paths to liquidity.

Founders & company background

Glooko was founded in 2010 by Yogen Dalal, Sundeep Madra, Anand Iyer and is headquartered in Palo Alto, CA.

Industry

Similar private companies

Talk to a Glooko stock specialist

Get personalized guidance on your Glooko shares — including current market activity, pricing context, and liquidity options.

Speak with an expert

Frequently asked questions

Is Glooko a public or private company?
Glooko is a private company as of the most recent data available. Its shares do not trade on a public stock exchange. Employees and early shareholders who want liquidity may need to explore secondary-market options or wait for a future IPO or acquisition.
What is Glooko's valuation?
Glooko's valuation has not been publicly disclosed. Private company valuations are typically set during funding rounds and are not always reported publicly.
What is Glooko's stock price per share?
Glooko does not trade on a public exchange, so there is no single live stock price. Indicative pricing may be available through secondary-market platforms. The most recent known valuation data can help frame expectations, but common shares typically trade at a discount to the headline preferred-stock valuation.
When will Glooko IPO?
Glooko has not announced a confirmed IPO date. IPO timing depends on market conditions, company financials, and board decisions. Employees should plan around the possibility that liquidity may take years and consider whether secondary-market options or company-sponsored tender offers are available in the interim.
Can I sell my Glooko stock?
It depends on what you hold and your company's policies. Vested, exercised shares are generally eligible for secondary-market sales, subject to Glooko's transfer restrictions and right of first refusal (ROFR). Unexercised options and unvested RSUs typically cannot be sold. Some companies also run periodic tender offers that allow employees to sell a portion of their holdings at a set price. Check your equity agreement or speak with your stock plan administrator for Glooko-specific rules.
How much does it cost to exercise Glooko stock options?
The out-of-pocket cost equals your strike price multiplied by the number of shares you exercise. For ISOs, exercising may also trigger the Alternative Minimum Tax (AMT) based on the spread between your strike price and the current fair market value. For NSOs, the spread is taxed as ordinary income at exercise. Use our AMT Calculator and Stock Option Tax Calculator to model the cost for your specific situation.
What type of stock options does Glooko grant — ISOs or NSOs?
Most venture-backed companies grant ISOs (Incentive Stock Options) to U.S. employees where possible, with NSOs (Non-Qualified Stock Options) used for amounts exceeding the $100K annual ISO limit, for contractors, or for non-U.S. employees. Your specific grant type is listed in your option agreement. The distinction matters because ISOs can qualify for long-term capital gains treatment, while NSOs are taxed as ordinary income at exercise. See our ISO guide and NSO guide for the full breakdown.
What happens to my Glooko stock if the company is acquired?
In an acquisition, your equity outcome depends on the deal structure and your grant terms. Common scenarios include cash-out (your shares are bought at a set price per share), rollover (your shares convert into the acquirer's equity), or cancellation with an acceleration clause. If you have double-trigger acceleration, your unvested shares may accelerate only if you are also terminated. The liquidation preference stack determines how proceeds are divided — preferred shareholders are paid first, which can reduce or eliminate the payout to common shareholders in lower-value exits.
What is the difference between common and preferred Glooko stock?
Employees typically hold common stock (or options on common stock). Investors hold preferred stock, which usually comes with a liquidation preference — meaning investors get paid first in an exit before common shareholders receive anything. This distinction is critical when estimating what your shares might actually be worth in an exit.
What happens to my Glooko options if I leave?
When you leave a company, you typically have a limited post-termination exercise window — often 90 days — to exercise your vested options or they expire worthless. Some companies offer extended windows (up to 10 years). Unvested options are forfeited. If you hold ISOs and don't exercise within 90 days of leaving, they convert to NSOs, which changes the tax treatment. Review your option agreement for Glooko's specific terms, and use our Exercise Timing Planner to model the financial tradeoffs.

Related pages

Last verified: 2026-05-28 · Glooko data compiled from funding disclosures, corporate filings, and public records.

Information on this page is compiled from publicly available sources and may be outdated or incomplete. This is not investment advice. Consult a qualified advisor before making financial decisions.